Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori

BACKGROUND: Helicobacter pylori (HP) infection is associated with reduced lung function and systemic inflammation in chronic obstructive pulmonary disease (COPD) patients. Azithromycin (AZ) is active against HP and reduces the risk of COPD exacerbation. We determined whether HP infection status modi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Respir Res
Hoofdauteurs: Ra, Seung Won, Sze, Marc A., Lee, Eun Chong, Tam, Sheena, Oh, Yeni, Fishbane, Nick, Criner, Gerard J., Woodruff, Prescott G., Lazarus, Stephen C., Albert, Richard, Connett, John E., Han, Meilan K., Martinez, Fernando J., Aaron, Shawn D., Reed, Robert M., Man, S. F. Paul, Sin, Don D.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2017
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450077/
https://ncbi.nlm.nih.gov/pubmed/28558695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-017-0594-x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items